HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Penberol

RN given refers to cpd without isomeric designation; structure

Also Known As:

Penberol, (E)-isomer; Penberol, (Z)-isomer; beta-4-n-pentoxybenzoyl-beta-bromacrylic acid

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acrylates: 212
      - Penberol: 3

Related Diseases

1.	Carcinoma (Carcinomatosis) 01/01/1983 - "Survival of patients with advanced ovarian carcinoma treated with Penberol." 01/01/1980 - "The authors present results of a preliminary study on the efficiency of the preparation Penberol [VUFB Prague (cis-beta-4-pentoxy-benzoyl-beta-bromoacrylic acid) CHECO protocol number 4] in the ovarian carcinoma of the stage III and IV (FIGO) in which the drug was used after the failure of the first choice chemotherapy. " 01/01/1983 - "The authors report their results of treatment in patients with ovarian carcinoma (stages III and IV, FIGO classification) with the cytostatic Penberol (cis-beta-4-pentoxybenzoyl-beta-bromoacrylic acid), synthesized at the Research Institute for Pharmacy and Biochemistry in Prague. " 01/01/1980 - "Preliminary results with the new cytostatic Penberol in ovarian carcinoma."
2.	Neoplasms (Cancer) 01/01/1977 - "Clinical experiences with Penberol (cis-beta-4-pentoxybenzoyl-beta-bromoacrylic acid) administered to patients with advanced neoplasias."

Related Drugs and Biologics

1.	Cytostatic Agents

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)